Pasithea Therapeutics Corp's total assets for Q1 2025 were $14.66B, an increase of 91149.54% from the previous quarter. KTTA total liabilities were $1.68B for the fiscal quarter, a 130956.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.